COMPASS THERAPEUTICS, INC. Net Income
COMPASS THERAPEUTICS, INC. (CMPX) reported Net Income of -$25.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$25.15M.
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$18.32M.
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$15.72M.
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$14.26M.
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2023 was -$42.49M.
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2022 was -$39.23M.
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2021 was -$82.18M.
- COMPASS THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2020 was -$29.50M.
| Period end | Net Income (Loss) Attributable to Parent 0 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$25.15M 10-Q · filed 2026-08-06 | -$43.47M 10-Q · filed 2026-08-06 | -$59.19M derived: sum of 3 quarters · filed 2026-08-06 | -$73.45M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$18.32M 10-Q · filed 2026-08-06 | -$34.03M derived: sum of 2 quarters · filed 2026-08-06 | -$48.29M derived: sum of 3 quarters · filed 2026-08-06 | -$68.17M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$15.72M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-29 | -$29.98M derived: sum of 2 quarters · filed 2026-04-29 | -$49.86M derived: sum of 3 quarters · filed 2026-08-06 | -$66.49M DEF 14A · filed 2026-04-29 | ||
| 2025-09-30 | -$14.26M 10-Q · filed 2025-11-05 | -$34.14M derived: sum of 2 quarters · filed 2026-08-06 | -$50.77M 10-Q · filed 2025-11-05 | -$65.81M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$19.88M 10-Q · filed 2026-08-06 | -$36.51M 10-Q · filed 2026-08-06 | -$51.55M derived: sum of 3 quarters · filed 2026-08-06 | -$62.03M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$16.63M 10-Q · filed 2026-08-06 | -$31.67M derived: sum of 2 quarters · filed 2026-08-06 | -$42.15M derived: sum of 3 quarters · filed 2026-08-06 | -$55.22M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2024-12-31 | -$15.03M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-29 | -$25.51M derived: sum of 2 quarters · filed 2026-04-29 | -$38.59M derived: sum of 3 quarters · filed 2026-04-29 | -$49.38M DEF 14A · filed 2026-04-29 | ||
| 2024-09-30 | -$10.48M 10-Q · filed 2025-11-05 | -$23.56M derived: sum of 2 quarters · filed 2025-11-05 | -$34.34M 10-Q · filed 2025-11-05 | -$47.76M derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | -$13.08M 10-Q · filed 2025-11-05 | -$23.86M 10-Q · filed 2025-08-11 | -$37.28M derived: sum of 3 quarters · filed 2025-11-05 | -$47.24M derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-03-31 | -$10.79M 10-Q · filed 2025-11-05 | -$24.20M derived: sum of 2 quarters · filed 2025-11-05 | -$34.17M derived: sum of 3 quarters · filed 2025-11-05 | -$45.44M derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2023-12-31 | -$13.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$23.38M derived: sum of 2 quarters · filed 2025-02-27 | -$34.66M derived: sum of 3 quarters · filed 2025-02-27 | -$42.49M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | -$9.96M 10-Q · filed 2024-11-12 | -$21.24M derived: sum of 2 quarters · filed 2024-11-12 | -$29.08M 10-Q · filed 2024-11-12 | -$40.67M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$11.28M 10-Q · filed 2024-11-12 | -$19.11M 10-Q · filed 2024-08-12 | -$30.71M derived: sum of 3 quarters · filed 2024-11-12 | -$42.68M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-03-31 | -$7.84M 10-Q · filed 2024-11-12 | -$19.43M derived: sum of 2 quarters · filed 2024-11-12 | -$31.41M derived: sum of 3 quarters · filed 2024-11-12 | -$39.90M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2022-12-31 | -$11.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$23.57M derived: sum of 2 quarters · filed 2024-03-21 | -$32.06M derived: sum of 3 quarters · filed 2024-03-21 | -$39.23M 10-K · filed 2024-03-21 | ||
| 2022-09-30 | -$11.97M 10-Q · filed 2023-11-09 | -$20.47M derived: sum of 2 quarters · filed 2023-11-09 | -$27.63M 10-Q · filed 2023-11-09 | -$40.61M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | -$8.49M 10-Q · filed 2023-11-09 | -$15.66M 10-Q · filed 2023-08-03 | -$28.64M derived: sum of 3 quarters · filed 2023-11-09 | -$34.61M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-03-31 | -$7.16M 10-Q · filed 2023-11-09 | -$20.14M derived: sum of 2 quarters · filed 2023-11-09 | -$26.12M derived: sum of 3 quarters · filed 2023-11-09 | -$81.92M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2021-12-31 | -$12.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$18.96M derived: sum of 2 quarters · filed 2023-03-15 | -$74.76M derived: sum of 3 quarters · filed 2023-03-15 | -$82.18M 10-K · filed 2023-03-15 | ||
| 2021-09-30 | -$5.97M 10-Q · filed 2022-11-09 | -$61.78M derived: sum of 2 quarters · filed 2022-11-09 | -$69.20M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$55.80M 10-Q · filed 2022-11-09 | -$63.22M 10-Q · filed 2022-08-01 | ||||
| 2021-06-20 | -$55.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | -$63.22M 10-Q · filed 2022-08-01 | -$71.61M derived: sum of 3 quarters · filed 2022-11-09 | -$80.76M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-03-31 | -$7.42M 10-Q · filed 2022-11-09 | -$15.81M derived: sum of 2 quarters · filed 2022-11-09 | -$24.96M derived: sum of 3 quarters · filed 2022-11-09 | -$30.52M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2020-12-31 | -$8.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$17.54M derived: sum of 2 quarters · filed 2022-03-18 | -$23.10M derived: sum of 3 quarters · filed 2022-03-18 | -$29.50M 10-K · filed 2022-03-18 | ||
| 2020-09-30 | -$9.15M 10-Q · filed 2021-11-12 | -$14.71M derived: sum of 2 quarters · filed 2021-11-12 | -$21.11M 10-Q · filed 2021-11-12 | -$21.12M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$5.56M 10-Q · filed 2021-08-16 | -$11.96M 10-Q · filed 2021-08-16 | -$11.97M derived: sum of 3 quarters · filed 2021-08-16 | -$20.52M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | -$6.40M 10-Q · filed 2021-04-30 | -$6.41M derived: sum of 2 quarters · filed 2021-04-30 | -$14.97M derived: sum of 3 quarters · filed 2021-04-30 | -$37.48K 10-K · filed 2020-06-08 | ||
| 2019-12-31 | -$11.68K 10-Q · filed 2020-02-14 | -$8.56M derived: sum of 2 quarters · filed 2020-11-09 | -$31.55K 10-Q · filed 2020-02-14 | -$34.74M 10-K · filed 2021-03-05 | ||
| 2019-09-30 | -$8.55M 10-Q · filed 2020-11-09 | -$8.40K 10-Q · filed 2019-11-13 | -$19.86K 10-Q · filed 2019-11-13 | -$28.13M 10-Q · filed 2020-11-09 | -$28.14M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | -$8.81M 10-Q · filed 2020-11-09 | -$11.46K 10-Q · filed 2019-08-13 | -$19.58M 10-Q · filed 2020-08-13 | -$19.59M derived: sum of 3 quarters · filed 2020-11-09 | -$19.60M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-03-31 | -$10.77M 10-Q · filed 2020-11-09 | -$10.78M derived: sum of 2 quarters · filed 2020-11-09 | -$10.79M derived: sum of 3 quarters · filed 2020-11-09 | -$36.04K 10-K · filed 2020-06-08 | ||
| 2018-12-31 | -$10.14K 10-Q · filed 2020-02-14 | -$18.70K derived: sum of 2 quarters · filed 2020-02-14 | -$27.17K 10-Q · filed 2020-02-14 | |||
| 2018-09-30 | -$8.56K 10-Q · filed 2019-11-13 | -$17.03K 10-Q · filed 2019-11-13 | ||||
| 2018-06-30 | -$8.47K 10-Q · filed 2019-08-13 | |||||
| 2018-03-31 | -$35.05K 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |